AC Immune (ACIU) Receivables - Other (2016 - 2025)

AC Immune (ACIU) has disclosed Receivables - Other for 7 consecutive years, with $1.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Receivables - Other rose 79.72% to $1.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.3 million, a 79.72% increase, with the full-year FY2024 number at $1.3 million, up 81.97% from a year prior.
  • Receivables - Other was $1.3 million for Q4 2024 at AC Immune, up from $701214.5 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.3 million in Q4 2024 to a low of $406904.6 in Q4 2022.
  • A 4-year average of $708131.5 and a median of $582690.7 in 2023 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: decreased 12.34% in 2022, then soared 79.72% in 2024.
  • AC Immune's Receivables - Other stood at $464166.9 in 2021, then fell by 12.34% to $406904.6 in 2022, then soared by 72.33% to $701214.5 in 2023, then surged by 79.72% to $1.3 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Receivables - Other are $1.3 million (Q4 2024), $701214.5 (Q4 2023), and $406904.6 (Q4 2022).